Adherence rates with infliximab therapy in Crohn's disease.

Adherence rates with infliximab therapy in Crohn's disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Adherence rates with infliximab therapy in Crohn's disease. Abstract Text:

S Kane,L Dixon,

BACKGROUND: Inflammatory bowel disease is associated with non-adherence to treatment with oral medications. AIM: To assess the intravenous infliximab adherence rate and identify risk factors for non-adherence to treatment. METHODS: Infliximab infusion dates for 1 June 2002-30 October 2003 were obtained. Additional information was obtained from two other administrative and patient-based databases. Non-adherence was defined as a 'No Show' designation for a scheduled appointment. Non-adherence rate, odds ratios for associations to 'No Show' appointments and analysis were performed to identify patient characteristics associated with non-adherent behaviour. RESULTS: One thousand hundred and eighty-five infliximab infusions were scheduled for 274 patients. Forty-eight (4%) of appointments were classified as 'No Show'. Six patients accounted for 13/48 (27%) of failed appointments; another 35 patients missed one appointment. 'No Show' appointments were more likely to be for female patients, those on concomitant immunomodulators and those >18 weeks from initial infusion. Patients who missed >1 appointment were more likely to be female and have Medicaid vs. those with only one missed appointment (P < 0.05). Indication, patient area code and race were not significantly associated with single or repeated No Show behaviour. CONCLUSIONS: Overall, the non-adherence rate for infliximab is low. Risk factors that may contribute to non-adherence to treatment include female gender and maintenance dosing.

Adherence rates with infliximab therapy in Crohn's disease. Publishing Authors By Initials

S Kane,L Dixon,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Adherence rates with infliximab therapy in Crohn's disease. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Alimentary pharmacology & therapeutics

VOLUME: 24

Page Numbers: 1099-103

Journal Abbreviation:

ISSN: 0269-2813

DAY: 1

MONTH: Oct

YEAR: 2006

Adherence rates with infliximab therapy in Crohn's disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8707234

Adherence rates with infliximab therapy in Crohn's disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Adherence rates with infliximab therapy in Crohn's disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Adherence rates with infliximab therapy in Crohn's disease.

AFFILIATION: Department of Medicine, University of Chicago, Chicago, IL 60637, USA. skane@medicine.bsd.uchicago.edu

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Aliment Pharmacol Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Adherence rates with infliximab therapy in Crohn's disease Related Publications

• A population-based needs assessment for mental health services.
• Adherence rates with infliximab therapy in Crohn's disease.
• Aromatase inhibitors--gene discovery.
• Cloning and characterization of a cDNA encoding walleye (Sander vitreum) beta-2 microglobulin.
• Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury.
• Depressive symptoms, cardiovascular risk, and diabetes self-care strategies in African American women with type 2 diabetes.
• Embolic protection of saphenous vein graft percutaneous interventions.
• Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury.
• Heats of formation and singlet-triplet separations of hydroxymethylene and 1-hydroxyethylidene.
• Immunopathogenicity and oncogenicity of murine leukemia viruses. II. Infection of mice and rats with Scripps leukemia virus.
• Impact of patients' socioeconomic status on the distance travelled for hospital admission in the English National Health Service.
• Influence of salinity and fish species on PAH uptake from dispersed crude oil.
• Interactions of bacterial effector proteins with host proteins.
• Interactive effects of metals in mixtures on bioaccumulation in the amphipod Hyalella azteca.
• Molecular epidemiology of African swine fever virus studied by analysis of four variable genome regions.
• Predicting the energy of the water exchange reaction and free energy of solvation for the uranyl ion in aqueous solution.
• Ps14 factors influencing the timing of the exit procedure for obstructing fetal neck masses.
• Radiographic texture analysis of densitometer-generated calcaneus images differentiates postmenopausal women with and without fractures.
• Reliability of spot test kits for detecting lead in household dust.
• Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury.
• Site-isolated base- and acid-mediated Michael-initiated cyclization cascades.
• Special issue: membranes.
• Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration.
• The cup is both half empty and half full.
• The outer mitochondrial membrane protein mitoNEET contains a novel redox-active 2Fe-2S cluster.
• The participation of the Na+-Ca2+ exchanger in primary cardiac myofibroblast migration, contraction, and proliferation.
• The pds2 mutation is a lesion in the Arabidopsis homogentisate solanesyltransferase gene involved in plastoquinone biosynthesis.
• The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease.
• The structure of acetyldihydrolipoic acid.
• Who should lead?